AN2 Therapeutics, Inc. - Common Stock and Warrants (ANTX)

42 filings reported holding ANTX - AN2 Therapeutics, Inc. - Common Stock and Warrants as of Q1 2025.
AN2 Therapeutics, Inc. - Common Stock and Warrants (ANTX) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.3M shares of 27.5M outstanding shares and own 52.21% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (5.75M shares), Almitas Capital LLC (1.31M shares), VANGUARD GROUP INC (1.04M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1M shares), Pfizer Inc (715K shares), Peapod Lane Capital LLC (581K shares), BANK OF NOVA SCOTIA (459K shares), TWO SIGMA ADVISERS, LP (445K shares), BANK OF MONTREAL /CAN/ (422K shares), and Aldebaran Capital, LLC (407K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.